Rhodiocyanoside D

Details

Top
Internal ID 2e72c385-03bf-4446-af13-cad730c06a18
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > Cyanogenic glycosides
IUPAC Name (E)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]but-2-enenitrile
SMILES (Canonical) CC=C(COC1C(C(C(C(O1)CO)O)O)O)C#N
SMILES (Isomeric) C/C=C(/CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)\C#N
InChI InChI=1S/C11H17NO6/c1-2-6(3-12)5-17-11-10(16)9(15)8(14)7(4-13)18-11/h2,7-11,13-16H,4-5H2,1H3/b6-2+/t7-,8-,9+,10-,11-/m1/s1
InChI Key UMDGSPMIRLGQIM-ZCIPGPJXSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C11H17NO6
Molecular Weight 259.26 g/mol
Exact Mass 259.10558726 g/mol
Topological Polar Surface Area (TPSA) 123.00 Ų
XlogP -1.80
Atomic LogP (AlogP) -1.73
H-Bond Acceptor 7
H-Bond Donor 4
Rotatable Bonds 4

Synonyms

Top
197508-56-8
(E)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]but-2-enenitrile
SCHEMBL6142797
2-(beta-D-Glucopyranosyloxymethyl)-2-butenenitrile
2-Butenenitrile, 2-((beta-D-glucopyranosyloxy)- methyl)-, (2E)-

2D Structure

Top
2D Structure of Rhodiocyanoside D

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8258 82.58%
Caco-2 - 0.8834 88.34%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.7326 73.26%
OATP2B1 inhibitior - 0.8609 86.09%
OATP1B1 inhibitior + 0.8733 87.33%
OATP1B3 inhibitior + 0.9576 95.76%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.8865 88.65%
P-glycoprotein inhibitior - 0.9334 93.34%
P-glycoprotein substrate - 0.9705 97.05%
CYP3A4 substrate - 0.5203 52.03%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8520 85.20%
CYP3A4 inhibition - 0.9625 96.25%
CYP2C9 inhibition - 0.8533 85.33%
CYP2C19 inhibition - 0.8739 87.39%
CYP2D6 inhibition - 0.9133 91.33%
CYP1A2 inhibition - 0.8388 83.88%
CYP2C8 inhibition - 0.8731 87.31%
CYP inhibitory promiscuity - 0.7815 78.15%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.7076 70.76%
Eye corrosion - 0.9853 98.53%
Eye irritation - 0.9754 97.54%
Skin irritation - 0.8127 81.27%
Skin corrosion - 0.9513 95.13%
Ames mutagenesis - 0.7300 73.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6059 60.59%
Micronuclear - 0.7900 79.00%
Hepatotoxicity - 0.7966 79.66%
skin sensitisation - 0.8738 87.38%
Respiratory toxicity - 0.7111 71.11%
Reproductive toxicity + 0.5222 52.22%
Mitochondrial toxicity - 0.6125 61.25%
Nephrotoxicity + 0.5326 53.26%
Acute Oral Toxicity (c) III 0.4718 47.18%
Estrogen receptor binding - 0.8170 81.70%
Androgen receptor binding - 0.7163 71.63%
Thyroid receptor binding - 0.5697 56.97%
Glucocorticoid receptor binding - 0.5090 50.90%
Aromatase binding - 0.7343 73.43%
PPAR gamma - 0.5697 56.97%
Honey bee toxicity - 0.7112 71.12%
Biodegradation - 0.5250 52.50%
Crustacea aquatic toxicity - 0.8000 80.00%
Fish aquatic toxicity - 0.7410 74.10%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 94.52% 86.92%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.34% 96.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.70% 99.17%
CHEMBL3401 O75469 Pregnane X receptor 84.48% 94.73%
CHEMBL3589 P55263 Adenosine kinase 84.36% 98.05%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 84.22% 96.00%
CHEMBL226 P30542 Adenosine A1 receptor 84.10% 95.93%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 80.30% 95.83%

Cross-Links

Top
PubChem 6442230
NPASS NPC148358
LOTUS LTS0018061
wikiData Q105275496